NCT00079261View on ClinicalTrials.gov

Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

March 31, 2007

Conditions

LymphomaSmall Intestine Cancer

Interventions

DRUG

CHOP regimen

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

gemcitabine hydrochloride

DRUG

prednisone

DRUG

vincristine sulfate

Trial Locations (6)

2610

Algemeen Ziekenhuis Sint-Augustinus, Wilrijk

33076

Institut Bergonie, Bordeaux

41000

University Hospital Rebro, Zagreb

B-3000

U.Z. Gasthuisberg, Leuven

Unknown

National Cancer Institute - Cairo, Cairo

NL-6500 HB

Universitair Medisch Centrum St. Radboud - Nijmegen, Nijmegen

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00079261 - Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter